Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Gap Inc (GAP) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance

Zimmer Biomet Holdings IncTrade

Price performance (Past 24H)

Key statistics

Gap Inc vs Zimmer Biomet Holdings Inc — how do they compare? Gap Inc trades at $20.49 (market cap $7.55B), while Zimmer Biomet Holdings Inc trades at $95.02 (market cap $18.55B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 2.5× Gap Inc's market cap, and Gap Inc pays the higher dividend (3.34%). Which is the better fit depends on your goals.

GAPZBH
Market Cap
$7.55B$18.55B
Sector
Consumer CyclicalHealth
52-Week High
$29.13$107.71
52-Week Low
$18.35$79.58
Enterprise Value
$10.63B$25.61B
Dividend Yield
3.34%0.99%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Gap Inc

Gap Inc. (GAP) trades at $21.51, up 5.08% today, showing strong momentum amid a bullish technical outlook. The stock presents compelling value with a P/E of 8.32 and P/S of 0.52, well below industry averages. Recent earnings have mostly beaten expectations, with Q1 2026 EPS of $0.38 exceeding estimates. Revenue growth has stabilized at $15.1B for 2025, while net income margin improved to 5.59%. The company maintains solid cash flow generation with $464M net cash flow in 2025.

Gap offers attractive valuation upside with a consensus price target of $26.09 (21% potential). However, risks include ongoing investigations by Pomerantz Law Firm and competitive pressures in retail. The turnaround story appears credible with nine consecutive positive comps, but execution risks remain. Current technical indicators suggest the stock is approaching overbought territory with RSI above 70.

Zimmer Biomet Holdings Inc

ZBH trades at $97.78, up 1.27% today, with a bullish technical outlook supported by moving averages and recent earnings beats. The company reported Q2 2026 EPS of $2.07, exceeding expectations, and raised its 2026 outlook. Revenue growth remains steady at 4.8% year-over-year, though net income margin has moderated from 2023 peaks. Analyst consensus is a 'Buy' with a $103.56 price target, indicating modest upside potential from current levels.

The stock offers a balanced risk-reward profile with solid fundamentals and positive momentum, but faces headwinds from margin pressure and rising debt levels. Investors should weigh the strong institutional support and consistent earnings performance against competitive pressures and macroeconomic uncertainties affecting the medtech sector.

Returns comparison

Trailing returns across standard periods

About Gap Inc

Gap retails apparel, accessories, and personal-care products under the Gap, Old Navy, Banana Republic, and Athleta brands. Old Navy generates more than half of Gap's sales. The firm also operates e-commerce sites, outlet stores, and specialty stores under various Gap names. Gap operates nearly 3,000 stores in North America, Europe, and Asia and franchises about 600 stores in Asia, Europe, Latin America, and other regions. Gap was founded in 1969 and is based in San Francisco.

Read more on GAP

About Zimmer Biomet Holdings Inc

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.

Read more on ZBH